Parallel imports and the pricing of pharmaceutical products: evidence from the European Union
- 31 July 2004
- journal article
- other
- Published by Elsevier in Journal of Health Economics
- Vol. 23 (5) , 1035-1057
- https://doi.org/10.1016/j.jhealeco.2004.03.005
Abstract
No abstract availableKeywords
All Related Versions
This publication has 8 references indexed in Scilit:
- Should the US allow prescription drug reimports from Canada?Journal of Health Economics, 2002
- Cross-national price differences for pharmaceuticals: how large, and why?Journal of Health Economics, 2000
- Strategic Pricing of New PharmaceuticalsThe Review of Economics and Statistics, 1998
- The economics of parallel trade.PharmacoEconomics, 1998
- Generic Entry and the Pricing of PharmaceuticalsJournal of Economics & Management Strategy, 1997
- Pricing, Patent Loss and the Market for PharmaceuticalsSouthern Economic Journal, 1992
- Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug ActThe Journal of Law and Economics, 1992
- Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical IndustryBrookings Papers on Economic Activity. Microeconomics, 1991